Skip to main content
. 2016 Jan 5;6:18694. doi: 10.1038/srep18694

Figure 6. anti-IL-9Ab attenuated the severity of hepatic fibrosis.

Figure 6

(A) Histology was assessed by H&E staining. Fibrillar collagen deposition was evaluated by Masson staining (original magnification, ×400). Activated HSCs in liver sections were quantified by immunohistochemical staining of alpha-smooth muscle actin (α-SMA) (original magnification: ×400). (B) Comparison of Ishak fibrosis score between anti-IL-9Ab, PBS and IgG treated groups. (C) Comparison of relative intensity of α-SMA in anti-IL-9Ab, PBS and IgG treated groups. **p < 0.01 compared with control PBS or IgG treated mice. Data are shown as mean ± SD.